Biotech Company Intercept Explodes After Reporting Good News On Liver Disease Treatments

August 11, 2014 11:14 PM

8 0

Biotech Company Intercept Explodes After Reporting Good News On Liver Disease Treatments

Shares of Intercept Pharmaceuticals were up more than 65% in after hours trade on Monday after the company announced development updates for several of its drug candidates.

The company, which has a market cap of more than $US5 billion, also reported second quarter earnings, posting a larger than expected quarterly loss.

Also read: French premier Valls expected to launch presidential bid

Read more

To category page

Loading...